Venture
Areteia Therapeutics, Inc.
Latest Form D 2025-02-21- CIK 1937542
- State NC
- Biotechnology
- 1 Form D offering since 2022-07-14
- Total sold
- $360M
- across its one offering
- Rounds
- 1
- Form D offerings since 2022-07-14
- Latest round
- $360M
- 2022-07-14 · 021-452352
- Investors
- 16
- on the latest round
Connected
named in its Form D filingsRound timeline
amount sold · by first filed2022-07-14 · $360M
- 2022-07-14$360M021-452352
Hover a dot or row, or tab through the dots · bars scaled to the largest round ($360M)
Form D offerings
One line per offering, amendments folded in, newest first
| File | First filed | Latest | Sought | Sold | Investors | Exemptions |
|---|---|---|---|---|---|---|
| 021-452352 | First filed2022-07-14 | Latest2025-02-21 | Sought$445M | Sold$360M | Investors16 | Exemptions506(b) |
Who backs Areteia Therapeutics, Inc. — 1 inferred investor — and every Form D as filedSee plans
People
Named in Item 3 of its latest Form D, filed 2025-02-21
| Name | Relationship |
|---|---|
| Paul Berns | RelationshipDirector |
| Adam Koppel | RelationshipDirector |
| Ian Read | RelationshipDirector |
| Benjamin Gomez | RelationshipDirector |
| Michael E. Bozik | RelationshipDirector |
| Stephen Butts | RelationshipDirector |
| Jorge Bartolome | RelationshipExecutive Officer, Director |
| Elyse Stock | RelationshipDirector |
| Daniel Becker | RelationshipDirector |
| Christopher Courts | RelationshipExecutive Officer |
| Robin Walker | RelationshipExecutive Officer |
Sales compensation
Named in Item 12 of its Form D filings
| Recipient | CRD | Broker-dealer | Offerings |
|---|---|---|---|
| COWEN AND COMPANY, LLC | CRD7616 | Broker-dealer— | Offerings1 |
Facts
As its latest Form D states them
- Industry
- Biotechnology
- State
- North Carolina (NC)
- Exemptions
- Rule 506(b)
- First filed
- 2022-07-14
- Latest filing
- 2025-02-21
Who backs Areteia Therapeutics, Inc.
Form D names a startup's officers and directors, not its investors. The dashboard infers them — the venture funds whose own filings and people overlap this company's rounds — and lays every Form D and amendment it filed beside the totals above.
- Inferred investors — the funds and firms behind it, from co-filings and shared people
- Every Form D and amendment as filed, with what each one stated
- Its rounds in sequence: the gap between them and whether they grew
- Everyone its filings name, linked to their other companies, with its addresses and phone numbers
Part of the Venture plan — $140/mo at launch pricing ($350 list)
See plansExternal link: SEC Filings ↗